Skip to main content
Fig. 7 | BMC Pharmacology and Toxicology

Fig. 7

From: Can vildagliptin protect against radiation-induced premature ovarian failure? Insights into the AMPK and AKT signaling pathways

Fig. 7

Effect of vilda co-administration on radiation-induced changes in AMPK/AKT/CREB signaling pathway. (A) Ovarian tissue level of phosphorylated AMPK. (B) Ovarian tissue level of phosphorylated AKT. (C) Ovarian tissue level of phosphorylated CREB. Data are presented as mean ± S.D., a; significantly different from control group at p < 0.05 using one-way ANOVA, b; significantly different from radiation group at p < 0.05 using one-way ANOVA followed by Tukey-Kramer as a post-hoc test

Back to article page